Some, especially growth hormone releasing peptides, are typically taken away from meals, while others are not affected by food
No, it is not FDA-approved, and much of the evidence is preclinical
ARA-290 is still being actively studied for its possible role in nociception "mitigation"
GHK-Cu timing matters less for systemic effects, though evening administration may support overnight regenerative processes
In 1981, for example, a paper published in the International Journal of Clinical Pharmacology, Therapy, and Toxicology described a trial with six volunteers who experienced immediate sleep pressure after intravenous DSIP infusion, as well as increased sleep time, decreased sleep onset, and better sleep efficiency without any sedative effects.13 Three years later, two other human trials across ten test subjects with insomnia found that DSIP administration yielded statistically significant improvements in several key sleep measures fewer sleep arousals, greater sleep efficiency, and increased REM, spindle, and slow-wave sleep.14 The above studies had shortcomings, namely their very small sample sizes, but the sleep-improving effects in cases of insomnia point to DSIPs potential to live up to its name
This personal insight shaped his philosophy of precision, personalized care targeting internal biochemistry to improve external performance
